Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Solid Biosciences (SLDB) Other Non Operating Income (2017 - 2024)

Solid Biosciences (SLDB) has disclosed Other Non Operating Income for 8 consecutive years, with $199000.0 as the latest value for Q4 2024.

  • Quarterly Other Non Operating Income fell 26.3% to $199000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $652000.0 through Dec 2024, down 40.46% year-over-year, with the annual reading at $824000.0 for FY2025, 26.38% up from the prior year.
  • Other Non Operating Income hit $199000.0 in Q4 2024 for Solid Biosciences, down from $211000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $282000.0 in Q1 2023 to a low of -$355000.0 in Q4 2022.
  • Historically, Other Non Operating Income has averaged $97857.1 across 5 years, with a median of $101000.0 in 2021.
  • Biggest five-year swings in Other Non Operating Income: tumbled 200.0% in 2022 and later soared 8933.33% in 2023.
  • Year by year, Other Non Operating Income stood at $1000.0 in 2020, then surged by 200.0% to $3000.0 in 2021, then crashed by 11933.33% to -$355000.0 in 2022, then soared by 176.06% to $270000.0 in 2023, then fell by 26.3% to $199000.0 in 2024.
  • Business Quant data shows Other Non Operating Income for SLDB at $199000.0 in Q4 2024, $211000.0 in Q3 2024, and $239000.0 in Q2 2024.